Entering text into the input field will update the search result below

ATP Assay Market - Global Leaders & Different Growth Strategies Adopted By Them

Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.


  • Technology Enhancements in ATP Assay Probes.
  • Growth Prospects in Emerging Markets.

Overview of This Study:

The study involved four major activities in estimating the current size of the ATP Assay Market. Exhaustive secondary research was conducted to collect information on the market as well as its peer and parent markets.

The next step is to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both the top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the sizes of segments and subsegments.

Key Questions Addressed by the Report:

# Which are the top 10 players operating in the ATP assays market?

# What are the drivers, restraints, opportunities, and challenges of the market?

# What are the prevailing industry trends, and what is the current scenario in the market?

# What are the growth trends in the market at the segmental and overall levels?

# How is the market performing in different regions across the globe?

What the Market Looks Like?

The global ATP assays market size is projected to reach USD 315 million by 2024 from USD 191 million in 2019, at a CAGR of 10.5%.

Download PDF Brochure @ ATP Assays Market

Global Growth Boosters:

The ATP assays market is highly consolidated, with a few players competing for a larger market share. The top ten players account for more than half of the total market share, while other global and regional market players account for the remaining share.

Prominent players in this market include Merck KGaA (Germany), Thermo Fisher Scientific, Inc. (US), PerkinElmer, Inc. (US), Lonza Group (Switzerland), Promega Corporation (US), Hygiena, LLC. (US), Agilent Technologies, Inc. (US), Abcam plc. (UK), Danaher Corporation (US), BioThema AB (Sweden), Abnova Corporation (Taiwan), AAT Bioquest (US), PromoCell GmbH (Germany), BioVision, Inc. (US), Biotium (US), Canvax Biotech S.L. (Spain), Creative Bioarray (US), Elabscience (US) and MBL International Corporation (US).

Different Growth Strategies Adopted:

These players adopted various strategies such as partnerships, agreements, mergers, and acquisitions to expand their presence in the global ATP assays market.

Geographical Growth Scenario:

Asia Pacific is expected to witness the highest growth in the ATP assays market from 2019 to 2024

The global ATP assays market is segmented into five major regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. During the forecast period, the Asia Pacific market is estimated to grow at the highest CAGR, as several countries are witnessing a growing number of proteomics, genomics, and stem cell research activities, increasing research funding, rising investments by pharmaceutical & biotechnology companies, and the growing trend of research infrastructure modernization.

Speak to Analyst for More Details@ ATP Assays Market

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

Related Stocks

SymbolLast Price% Chg
Thermo Fisher Scientific Inc.
Lonza Group AG
Agilent Technologies, Inc.
Abcam plc
Danaher Corporation
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.